KERI LOWE: Open Payments
NPI 1609476456 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,264 in 81 payments from 17 companies in 2025. Trend: 2023 $1,609 · 2024 $1,136 · 2025 $1,264
Food & beverage: $1,264
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $347 |
| ABBVIE INC. | 28 | $296 |
| AstraZeneca Pharmaceuticals LP | 9 | $157 |
| Amgen Inc. | 11 | $143 |
| PFIZER INC. | 3 | $54 |
| Medtronic, Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Edwards Lifesciences Corporation | 1 | $25 |
Products named: Ozempic, VRAYLAR, OTEZLA, AIRSUPRA, Wegovy, UBRELVY, Rybelsus, INTELLIS ADAPTIVESTIM.
Industry payments across IN — which companies pay providers there.
